Tarbox Family Office’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-44
Closed -$2K 602
2022
Q1
$2K Hold
44
﹤0.01% 821
2021
Q4
$2K Hold
44
﹤0.01% 895
2021
Q3
$2K Hold
44
﹤0.01% 941
2021
Q2
$3K Hold
44
﹤0.01% 821
2021
Q1
$2K Hold
44
﹤0.01% 899
2020
Q4
$2K Hold
44
﹤0.01% 852
2020
Q3
$1K Hold
44
﹤0.01% 998
2020
Q2
$1K Hold
44
﹤0.01% 997
2020
Q1
$1K Buy
+44
New +$1.36K ﹤0.01% 902

Other funds holding LMAT

Tarbox Family Office's LMAT Position: Q2 2022 in Review

Tarbox Family Office sold out of LeMaitre Vascular (LMAT) in Q2 2022, closing a stake of 44 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in LMAT in Q1 2020 and held it in 9 quarters. The position peaked at $3K in Q2 2021. 179 funds tracked by Wall St. Rank hold LMAT as of Q2 2022.

  • Tarbox Family Office reported no remaining LeMaitre Vascular position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 44 LeMaitre Vascular shares in Q2 2022, an estimated $2K.
  • Tarbox Family Office first reported a position in LeMaitre Vascular in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's LeMaitre Vascular position peaked at $3K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.